Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Clinical results reported for Roche Bioscience's nepicastat

Nov. 11, 1997

Recordati signs licensing agreements with Zeneca, Zambon and Rotta for lercanidipine

Nov. 11, 1997

Selective PDE V inhibition with M-54033 beneficial in pulmonary hypertension

Nov. 11, 1997

New C5a antagonist reduces cardiac ischemia-reperfusion injury in micropig model

Nov. 11, 1997

Inhibitors of ECE prepared at Roussel Uclaf/INSERM

Nov. 10, 1997

New agents in development for restenosis

Nov. 10, 1997

Protein C and sepsis

Nov. 7, 1997

Antihypertensive and antianginal efficacy of mibefradil confirmed in clinical trials

Nov. 6, 1997

New avenue opened for the treatment of congestive heart failure

Nov. 5, 1997

Antihypertensive effects reported for kallikrein gene therapy

Nov. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.